Alkyl Caffeates as Anti-Helicobacter Pylori and Scavenger of Oxidants Produced by Neutrophils

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Inhibition of Lysozyme by Taurine Dibromamine

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Antifungal Activity of Decyl Gallate against Several Species of Pathogenic Fungi

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Improvement of Pro-Oxidant Capacity of Protocatechuic Acid by Esterification

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Perfis de Orfeu na poesia brasileira recente

Muitos são os atributos que perfazem o ciclo mítico de Orfeu, o mais importante dos poetas lendários da Grécia antiga: ele, além de amante devotado (pois desceu ao Hades em busca da amada Eurídice) e protótipo de poeta lírico (em termos ideais platônicos), teria sido o fundador do culto de mistérios que leva seu nome, o Orfismo. Tema recorrente na literatura e nas artes ocidentais, sobretudo a partir das obras dos latinos Ovídio e Virgílio, o mito de Orfeu, em seus aspectos mítico-poéticos, vinca a poesia brasileira desde a Colônia e atinge inusitada voga a partir dos anos 40/50 do século XX, quando pode encharcar-se de certos aspectos místico-religiosas (Murilo Mendes; Dora Ferreira da Silva). Na contemporaneidade, os perfis de Orfeu continuam seu périplo pela poesia brasileira, em obras recentes de Adriano Espínola (Praia provisória, 2006), Geraldo Carneiro (Balada do impostor, 2006) ou Rodrigo Petronio (Venho de um país selvagem, 2009). A partir de tais obras tentar-se-á dar um corpo (embora metamórfico) ao contraditório Orfeu.

Toxic heritage: maternal transfer of pyrethroid insecticides and sunscreen agents in dolphins from Brazil

Pyrethroids (PYR) and UV filters (UVF) were investigated in tissues of paired mother-fetus dolphins from Brazilian coast in order to investigate the possibility of maternal transfer of these emerging contaminants. Comparison of PYR and UVF concentrations in maternal and fetal blubber revealed Franciscana transferred efficiently both contaminants to fetuses (F/M > 1) and Guiana dolphin transferred efficiently PYR to fetuses (F/M > 1) different than UVF (F/M < 1). PYR and UVF concentrations in fetuses were the highest-ever reported in biota (up to 6640 and 11,530 ng/g lw, respectively). Muscle was the organ with the highest PYR and UVF concentrations (p < 0.001), suggesting that these two classes of emerging contaminants may have more affinity for proteins than for lipids. The high PYR and UVF concentrations found in fetuses demonstrate these compounds are efficiently transferred through placenta. This study is the first to report maternal transfer of pyrethroids and UV filters in marine mammals.

A review of the genus Speocarcinus Stimpson, 1859 (Crustacea: Brachyura: Xanthidae), with a key to its species and the description of one new species

Speocarcinus dentatus n. sp. is described from the southwestern Atlantic. The new species can be easily separated from its congeners by a suite of carapace and appendage characters. Speocarcinus Stimpson, 1859, now includes eight extant species, all from the Atlantic or Pacific coasts of the Americas. Additional characters to further differentiate between S. carolinensis Stimpson, 1859, and S. lobatus Guinot, 1969, and between S. granulimanus Rathbun, 1894, and S. spinicarpus Guinot, 1969 are documented. The lectotype of S. granulimanus is first described and a key to the species of Speocarcinus is provided.

Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): Study protocol for a randomized controlled trial

Background: Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). Methods/Design: ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH(2)O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure <= 30 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. Discussion: If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration method.

Un'applicazione iOS per la gestione delle designazioni arbitrali

L’obiettivo della tesi è quello di sviluppare un’applicazione mobile per iOS al fine di creare un servizio all’utente che semplifichi il processo di consultazione della designazione della gara. Ho iniziato la mia esperienza arbitrale nell’Ottobre del 2008, quando per curiosità mi sono iscritto al corso gratuito organizzato dalla sezione di Bologna; da quel momento fare l’arbitro è diventata una passione. L’idea di sviluppare un’applicazione mobile è nata nel momento in cui ho riscontrato difficoltà, insieme ai miei colleghi, nel consultare il portale Web ogni qualvolta si presentasse la necessità di visualizzare la designazione arbitrale. In mancanza di un’applicazione mobile che permettesse l’accesso al portale Web dell’associazione, denominato Sinfonia 4 You, ho preso in considerazione la possibilità di sviluppare questo servizio. Per rendere concreta l’idea, ho avuto bisogno del supporto informatico dell’Associazione Italiana Arbitri. Nel corso della mia carriera da arbitro, ho avuto modo di conoscere i responsabili informatici nazionali dell’associazione, così da renderli partecipi della mia idea. Intuendo le potenzialita` del lavoro che volevo sviluppare, ho avuto la possibilità di essere invitato, attraverso il responsabile informatico della sezione di Bologna, nonché mio correlatore Luca Lipparini, di essere invitato a Coverciano (FI) per confrontarmi con il comitato informatico dell’associazione. All’incontro, ho avuto modo di far vedere una simulazione del prototipo che fino ad allora avevo sviluppato. Da quel momento, la collaborazione è stata concreta e fine ad un obiettivo comune. I responsabili hanno esposto la loro idea di volere già sviluppare un’applicazione mobile simile per le piattaforme Android e Windows Mobile. Tuttavia, la mia grande passione per il mondo Apple mi ha permesso di focalizzarmi sullo sviluppo dell’applicazione su iOS.

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

Whether the two drug-eluting stents approved by the US Food and Drug Administration-a sirolimus-eluting stent and a paclitaxel-eluting stent-are associated with increased risks of death, myocardial infarction, or stent thrombosis compared with bare-metal stents is uncertain. Our aim was to compare the safety and effectiveness of these stents.

Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry.

BACKGROUND The use of transcatheter mitral valve repair (TMVR) has gained widespread acceptance in Europe, but data on immediate success, safety, and long-term echocardiographic follow-up in real-world patients are still limited. OBJECTIVES The aim of this multinational registry is to present a real-world overview of TMVR use in Europe. METHODS The Transcatheter Valve Treatment Sentinel Pilot Registry is a prospective, independent, consecutive collection of individual patient data. RESULTS A total of 628 patients (mean age 74.2 ± 9.7 years, 63.1% men) underwent TMVR between January 2011 and December 2012 in 25 centers in 8 European countries. The prevalent pathogenesis was functional mitral regurgitation (FMR) (n = 452 [72.0%]). The majority of patients (85.5%) were highly symptomatic (New York Heart Association functional class III or higher), with a high logistic EuroSCORE (European System for Cardiac Operative Risk Evaluation) (20.4 ± 16.7%). Acute procedural success was high (95.4%) and similar in FMR and degenerative mitral regurgitation (p = 0.662). One clip was implanted in 61.4% of patients. In-hospital mortality was low (2.9%), without significant differences between groups. The estimated 1-year mortality was 15.3%, which was similar for FMR and degenerative mitral regurgitation. The estimated 1-year rate of rehospitalization because of heart failure was 22.8%, significantly higher in the FMR group (25.8% vs. 12.0%, p[log-rank] = 0.009). Paired echocardiographic data from the 1-year follow-up, available for 368 consecutive patients in 15 centers, showed a persistent reduction in the degree of mitral regurgitation at 1 year (6.0% of patients with severe mitral regurgitation). CONCLUSIONS This independent, contemporary registry shows that TMVR is associated with high immediate success, low complication rates, and sustained 1-year reduction of the severity of mitral regurgitation and improvement of clinical symptoms.

Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.

IMPORTANCE Owing to a considerable shift toward bioprosthesis implantation rather than mechanical valves, it is expected that patients will increasingly present with degenerated bioprostheses in the next few years. Transcatheter aortic valve-in-valve implantation is a less invasive approach for patients with structural valve deterioration; however, a comprehensive evaluation of survival after the procedure has not yet been performed. OBJECTIVE To determine the survival of patients after transcatheter valve-in-valve implantation inside failed surgical bioprosthetic valves. DESIGN, SETTING, AND PARTICIPANTS Correlates for survival were evaluated using a multinational valve-in-valve registry that included 459 patients with degenerated bioprosthetic valves undergoing valve-in-valve implantation between 2007 and May 2013 in 55 centers (mean age, 77.6 [SD, 9.8] years; 56% men; median Society of Thoracic Surgeons mortality prediction score, 9.8% [interquartile range, 7.7%-16%]). Surgical valves were classified as small (≤21 mm; 29.7%), intermediate (>21 and <25 mm; 39.3%), and large (≥25 mm; 31%). Implanted devices included both balloon- and self-expandable valves. MAIN OUTCOMES AND MEASURES Survival, stroke, and New York Heart Association functional class. RESULTS Modes of bioprosthesis failure were stenosis (n = 181 [39.4%]), regurgitation (n = 139 [30.3%]), and combined (n = 139 [30.3%]). The stenosis group had a higher percentage of small valves (37% vs 20.9% and 26.6% in the regurgitation and combined groups, respectively; P = .005). Within 1 month following valve-in-valve implantation, 35 (7.6%) patients died, 8 (1.7%) had major stroke, and 313 (92.6%) of surviving patients had good functional status (New York Heart Association class I/II). The overall 1-year Kaplan-Meier survival rate was 83.2% (95% CI, 80.8%-84.7%; 62 death events; 228 survivors). Patients in the stenosis group had worse 1-year survival (76.6%; 95% CI, 68.9%-83.1%; 34 deaths; 86 survivors) in comparison with the regurgitation group (91.2%; 95% CI, 85.7%-96.7%; 10 deaths; 76 survivors) and the combined group (83.9%; 95% CI, 76.8%-91%; 18 deaths; 66 survivors) (P = .01). Similarly, patients with small valves had worse 1-year survival (74.8% [95% CI, 66.2%-83.4%]; 27 deaths; 57 survivors) vs with intermediate-sized valves (81.8%; 95% CI, 75.3%-88.3%; 26 deaths; 92 survivors) and with large valves (93.3%; 95% CI, 85.7%-96.7%; 7 deaths; 73 survivors) (P = .001). Factors associated with mortality within 1 year included having small surgical bioprosthesis (≤21 mm; hazard ratio, 2.04; 95% CI, 1.14-3.67; P = .02) and baseline stenosis (vs regurgitation; hazard ratio, 3.07; 95% CI, 1.33-7.08; P = .008). CONCLUSIONS AND RELEVANCE In this registry of patients who underwent transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic valves, overall 1-year survival was 83.2%. Survival was lower among patients with small bioprostheses and those with predominant surgical valve stenosis.

Una profesión insólita y lucrativa : la captatio testamenti

El presente trabajo se propone: 1. Determinar las distintas formas de testar que adoptó el derecho romano, a lo largo de su evolución histórica. 2. Caracterizar la captatio testamenti, una profesión insólita y lucrativa cuya existencia se constata ya en la Roma republicana, a través del testimonio de Plauto en el Miles gloriosus y que se difundió notablemente durante los primeros siglos del Imperio, en los que se convirtió en un medio de progreso social. 3. Analizar esta actividad desde diferentes perspectivas de acuerdo con los tipos humanos que participan en ella: los captatores testamentorum o heredipetae y los testatores. El corpus trabajado abarca a Plauto (Miles gloriosus), Horacio (Sátira 2,5), Séneca (De beneficiis y Epist. 95), Marcial (Epigramas), Petronio (Satiricón), Juvenal (Sátira 12), Plinio el Viejo (Hist. Natural), Plinio el Joven (Epist. 2, 20).